Genetic_Overlap_between_Metabolic_and_Psychiatric_disease
The Genetic Overlap between Metabolic and Psychiatric Diseases (GOMAP) study comprises samples from four patient groups: 964 schizophrenia samples, 921 type 2 diabetes patients, 582 patients with comorbid schizophrenia and type 2 diabetes and 280 samples with another psychiatric diagnosis.
- Type: Whole Genome Sequencing
- Archiver: European Genome-Phenome Archive (EGA)
Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data
| Dataset ID | Description | Technology | Samples |
|---|---|---|---|
| EGAD00010001484 | Illumina HumanCoreExome-12v1-0 | 2611 |
| Publications | Citations |
|---|---|
|
Combination therapy as a potential risk factor for the development of type 2 diabetes in patients with schizophrenia: the GOMAP study.
BMC Psychiatry 18: 2018 249 |
0 |
|
Evidence for genetic contribution to the increased risk of type 2 diabetes in schizophrenia.
Transl Psychiatry 8: 2018 252 |
38 |